Search Results

Displaying Results 326-350 of 10828 "'F'"

Aug 31, 2026, 07:00 ET New Phase 3b data on Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together showed improved and durable efficacy at one year in adults with psoriatic disease and obesity

TOGETHER-PsA."Psoriatic disease is often accompanied by obesity or overweight, which can make treatment goals related to the skin and joints harder to reach," said Joseph F. Merola, M.D. MMSc, a Dermatologist, Rheumatologist, President of the Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network (PPACMAN),

More news about: Eli Lilly and Company


Aug 31, 2026, 07:00 ET Pulsenmore Ltd. Announces Financial Results and Business Highlights for the First Half of 2026

time to time with the SEC, including, but not limited to, the risks, uncertainties and other factors included in the Company's Annual Report on Form 20-F for the fiscal year ended December 31, 2025 and in subsequent filings with the SEC. The inclusion of forward-looking statements in this or any other communication

More news about: Pulsenmore Ltd.


Aug 31, 2026, 07:00 ET BioLineRx Reports Second Quarter 2026 Financial Results and Provides Corporate Update

factors discussed above. These and other factors are more fully discussed in the "Risk Factors" section of BioLineRx's most recent annual report on Form 20-F filed with the Securities and Exchange Commission on March 23, 2026. In addition, any forward-looking statements represent BioLineRx's views only as of

More news about: BioLineRx Ltd.


Aug 31, 2026, 06:45 ET Lilly to acquire Merida Biosciences to advance treatments for serious autoimmune and allergic diseases

LinkedIn. F-LLYAbout Merida BiosciencesMerida is advancing a precision immunology approach for antibody-driven diseases that selectively and

More news about: Eli Lilly and Company


Aug 31, 2026, 06:00 ET Ziihera® (zanidatamab-hrii) plus Chemotherapy Demonstrates Statistically Significant Overall Survival Benefit Versus Trastuzumab plus Chemotherapy in First-Line HER2+ Advanced GEA

1Bray F., et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for

More news about: Jazz Pharmaceuticals plc


Aug 31, 2026, 03:18 ET AMGEN'S REPATHA® REDUCES RISK OF DEATH IN PATIENTS AT HIGH RISK FOR A FIRST HEART ATTACK OR STROKE

Elissa Snook, 609-251-1407 (media) Casey Capparelli, 805-447-1746 (investors)REFERENCESEroglu T, Capone F, Schiattarella GG. The evolving landscape of cardiometabolic diseases. EBioMedicine. 2024 Nov;109:105447. doi: 10.1016/j.ebiom.2024.105447. Epub 2024

More news about: Amgen


Aug 31, 2026, 00:00 ET 후다 뷰티와 카디 비, 새로운 Ultra Snatched 컬렉션으로 한층 더 강렬한 리프팅 메이크업 선보여

multimedia:https://www.prnewswire.com/kr/news-releases/uD6C4uB2E4u002DuBDF0uD2F0uC640u002DuCE74uB514u002DuBE44u002Cu002DuC0C8uB85CuC6B4u002Du0075u006Cu0074u0072u0061u002Du0073u006Eu0061u0074u0063-302864419.htmlSOURCE

More news about: Huda Beauty


Aug 30, 2026, 22:00 ET 쭐라 연구팀, 돼지 농장 질병 발생 위험을 줄이는 천연 페로몬 모방 합성 수퇘지 냄새 개발

multimedia:https://www.prnewswire.com/kr/news-releases/uCB50uB77Cu002DuC5F0uAD6CuD300u002Cu002DuB3FCuC9C0u002DuB18DuC7A5u002DuC9C8uBCD1u002DuBC1CuC0DDu002DuC704uD5D8uC744u002DuC904uC774uB294u002D-302861662.htmlSOURCE

More news about: Chulalongkorn University Communication Center


Aug 30, 2026, 02:58 ET Yaber Launches Cordless Vacuum HP20: TÜV-Tested 180AW Suction, SGS-certified H13 HEPA Filtration, and SenseCleanAI AI Detection Under $200

store:https://www.amazon.com/gp/product/B0H2LWWYCX?maas=maas_adg_2F3844CE879126CA012EB35527CF1C50_afap_abs&ref_=aa_maas&tag=maas&th=1.

More news about: Yaber


Aug 29, 2026, 13:45 ET 시리아, 마스터카드와 QNB 그룹 통해 15년여 만에 첫 국제 카드 결제 처리

multimedia:https://www.prnewswire.com/kr/news-releases/uC2DCuB9ACuC544u002Cu002DuB9C8uC2A4uD130uCE74uB4DCuC640u002Du0071u006Eu0062u002DuADF8uB8F9u002DuD1B5uD574u002Du0031u0035uB144uC5ECu002DuB9CC-302864322.htmlSOURCE

More news about: Mastercard


Aug 28, 2026, 19:00 ET 24 Greenberg Traurig Attorneys, 11 Practices Recognized in 2027 Edition of Latin Lawyer 250

Richard F. Davis, Real Estate & Tourism,

More news about: Greenberg Traurig, LLP


Aug 28, 2026, 18:06 ET Power Metallic announces Marketing Programs

(Dry, crush (< 7 kg) up to 80% passing 2 mm, riffle split (250 g) and pulverize (mild steel) to 95% passing 105 μm) preparation methods, and using 1F2 (ICP-OES) and 1C-OES - 4-Acid near total digestion + Gold-Platinum-Palladium analysis and 8-Peroxide ICP-OES, for regular and over detection limit analysis.

More news about: Power Metallic Mines Inc.


Aug 28, 2026, 15:50 ET Wise F&I's Amy Counts Named 2026 NAMAD Woman of the Year

Core Value Award and a NAMAD Appreciation Award in 2004.In 2015, Counts joined Wise F&I, where she currently serves as Regional Vice President of Client Success. With over 10 years at Wise F&I, she has played an integral role in building strong relationships and supporting the success

More news about: Wise F&I


Aug 28, 2026, 12:06 ET Regeneron Pharmaceuticals, Inc. (REGN) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before September 14, 2026 Lead Plaintiff Deadline

youtu.be/rsW1-f8ARRsClass Period: Aug. 1, 2025 – May 15, 2026Lead Plaintiff Deadline: Sept. 14, 2026Visit: 

More news about: Hagens Berman Sobol Shapiro LLP


Aug 28, 2026, 10:49 ET /C O R R E C T I O N -- FlyteHealth/

the Hubert H. Humphrey Building in Washington, D.C., hosted by the U.S. Department of Health and Human Services and CMS on behalf of Secretary Robert F. Kennedy Jr. and CMS Administrator Dr. Mehmet Oz.

More news about: FlyteHealth


Aug 28, 2026, 10:15 ET mHealth Solutions Market worth $275.44 billion by 2031 - Exclusive Report by MarketsandMarkets™

management, personalized health insights, and care delivery outside traditional healthcare settings. In December 2024, Oura raised USD 200 million in Series F funding to expand its connected health platform and health-monitoring capabilities. Its smart ring and mobile application enable continuous tracking of

More news about: MarketsandMarkets


Aug 28, 2026, 09:00 ET FLOWERS FOODS DECLARES QUARTERLY DIVIDEND

developing and introducing new products and entering new markets, (e) our ability to implement new technology and customer requirements as required, (f) our ability to operate existing, and any new, manufacturing lines according to schedule, (g) our ability to implement and achieve our corporate responsibility

More news about: Flowers Foods, Inc.


Aug 28, 2026, 08:56 ET 화웨이, 2026년 가트너® 매직 쿼드런트™ 엔터프라이즈 스토리지 플랫폼 부문 리더로 선정

multimedia:https://www.prnewswire.com/kr/news-releases/uD654uC6E8uC774u002Cu002Du0032u0030u0032u0036uB144u002DuAC00uD2B8uB108u00AEu002DuB9E4uC9C1u002DuCFFCuB4DCuB7F0uD2B8u2122u002DuC5D4uD130uD504-302862807.htmlSOURCE

More news about: 화웨이


Aug 28, 2026, 08:30 ET Leifras Celebrates 25th Anniversary, Setting Vision for Becoming Global Infrastructure Through "Sports and Social"

limited to, the uncertainties related to market conditions, and other factors discussed in the "Risk Factors" section of the annual report on Form 20-F filed with the U.S. Securities and Exchange Commission (the "SEC"). Although the Company believes that the expectations expressed in these forward-looking

More news about: LEIFRAS Co., Ltd.


Aug 28, 2026, 08:00 ET BioLineRx Announces $3.75 Million Registered Direct Offering and Concurrent Private Placement

factors discussed above. These and other factors are more fully discussed in the "Risk Factors" section of BioLineRx's most recent annual report on Form 20-F filed with the Securities and Exchange Commission on March 27, 2026. In addition, any forward-looking statements represent BioLineRx's views only as of

More news about: BioLineRx Ltd.


Aug 28, 2026, 07:30 ET Kazia Therapeutics Limited Announces Pricing of Up to $120 Million Public Offering

indications, and for working capital and general corporate purposes.The ADSs and warrants are being offered pursuant to a registration statement on Form F-3 (File No. 333-294392), which was previously filed with and subsequently declared effective by the Securities and Exchange Commission (the "SEC"). The

More news about: Kazia Therapeutics Limited


Aug 28, 2026, 07:17 ET Eucalyptus Resources Issues Letter to Shareholders Calling for an Upgrade of the Board of TNR Gold

appointed CEO of TNR Gold he proclaimed one of his principal goals to be to "minimise dilution". It's hard to give this objective any grade except an 'F', having expanded the float by over 60%, issuing over 90,000,000 shares. Many of these have been to himself and other insiders, with Kirill Klip exercising

More news about: Eucalyptus Resources Opportunities Fund 1, LP


Aug 28, 2026, 07:00 ET Lasfit Expands Its Vehicle-Specific Ford F-150 Upgrade Solutions Across Lighting, Protection and Outdoor Use

Lasfit's F-150 upgrades, ranging from daily driving lighting and interior floor protection to newly expanded off-road functional accessories.Revamped F-150 Lighting Range Caters to Diverse Usage ScenariosThe newly released LED ditch lights are engineered specifically for F-150 owners

More news about: LASFIT


Aug 28, 2026, 06:27 ET 글로벌 티어1 기업 와이포어, 애틀랜타에 미국 제조공장 출범

multimedia:https://www.prnewswire.com/kr/news-releases/uAE00uB85CuBC8Cu002DuD2F0uC5B4u0031u002DuAE30uC5C5u002DuC640uC774uD3ECuC5B4u002Cu002DuC560uD2C0uB79CuD0C0uC5D0u002DuBBF8uAD6Du002DuC81CuC870-302862712.htmlSOURCE

More news about: YFORE


Aug 28, 2026, 06:16 ET 테스트뮤 콘퍼런스 2026: 테스트뮤 AI의 플래그십 행사, 에이전틱 엔지니어링과 품질 분야의 새로운 이정표 제시

multimedia:https://www.prnewswire.com/kr/news-releases/uD14CuC2A4uD2B8uBBA4u002DuCF58uD37CuB7F0uC2A4u002Du0032u0030u0032u0036u003Au002DuD14CuC2A4uD2B8uBBA4u002Du0061u0069uC758u002DuD50CuB798uADF8-302862706.htmlSOURCE

More news about: TestMu AI (Formerly LambdaTest)


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.